Just my opinion of course, two things: Disappointment on...

Just my opinion of course, two things: Disappointment on Epichem's lack of growth the first half after it seemed to be on a roll the previous year. And the 2 1/2 year delay in getting the MPL ph 2 trial off the ground because of palatability issues and earlier false hopes it had been solved. People have become sceptical and now want to see the trials first before committing. Let's hope that they've finally cracked this tough nut like they said they have. We'll know in the coming months. Somebody suggested that had they not promised so much so soon, the sp would now be higher.